Lambrecht R M, Packer S, Wolf A P, Lloyd D, Atkins H L
J Nucl Med. 1984 Jul;25(7):800-4.
Iodine-123-labeled 4-(3-dimethylpropylamino)-7-iodoquinoline was evaluated in nine patients. By using a specially designed dual-pinhole ocular collimator, it was possible to obtain positive images at 2-6 hr for only 70% of the cases with subsequently proven ocular melanomas.